Advertisement
A vs ATR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Buy and ATR is a StrongBuy.
Aroon Indicator for A shows an upward move is likely
A's Aroon Indicator triggered a bullish signal on October 20, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 209 similar instances where the Aroon Indicator showed a similar pattern. In 141 of the 209 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on A as a result. In 57 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
Following a +2.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where A advanced for three days, in 186 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
Bearish Trend Analysis
The 10-day RSI Indicator for A moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 18 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 70 cases where A's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.
The Moving Average Convergence Divergence Histogram (MACD) for A turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 29 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where A declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
A broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 7 (best 1 - 100 worst), indicating outstanding price growth. A’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.625) is normal, around the industry mean (64.051). P/E Ratio (33.990) is within average values for comparable stocks, (1.569). Projected Growth (PEG Ratio) (1.447) is also within normal values, averaging (3.473). Dividend Yield (0.006) settles around the average of (0.002) among similar stocks. P/S Ratio (5.910) is also within normal values, averaging (9.775).
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. A’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
ATR's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for ATR turned positive on October 14, 2026. Looking at past instances where ATR's MACD turned positive, the stock continued to rise in 36 of 58 cases over the following month. The odds of a continued upward trend are 62%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ATR's RSI Indicator exited the oversold zone, 16 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 52%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on ATR as a result. In 46 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.
Following a +1.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATR advanced for three days, in 181 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
ATR broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ATR entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. ATR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.043) is normal, around the industry mean (4.940). P/E Ratio (22.459) is within average values for comparable stocks, (36.759). Projected Growth (PEG Ratio) (2.595) is also within normal values, averaging (4.456). Dividend Yield (0.015) settles around the average of (0.005) among similar stocks. P/S Ratio (2.072) is also within normal values, averaging (56.074).
The Tickeron Profit vs. Risk Rating rating for this company is 85 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
A | ATR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 28 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 24 Undervalued | 72 Overvalued | |
PROFIT vs RISK RATING 1..100 | 91 | 85 | |
SMR RATING 1..100 | 45 | 59 | |
PRICE GROWTH RATING 1..100 | 7 | 55 | |
P/E GROWTH RATING 1..100 | 39 | 39 | |
SEASONALITY SCORE 1..100 | n/a | 28 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
A's Valuation (24) in the Biotechnology industry is somewhat better than the same rating for ATR (72) in the Containers Or Packaging industry. This means that A’s stock grew somewhat faster than ATR’s over the last 12 months.
ATR's Profit vs Risk Rating (85) in the Containers Or Packaging industry is in the same range as A (91) in the Biotechnology industry. This means that ATR’s stock grew similarly to A’s over the last 12 months.
A's SMR Rating (45) in the Biotechnology industry is in the same range as ATR (59) in the Containers Or Packaging industry. This means that A’s stock grew similarly to ATR’s over the last 12 months.
A's Price Growth Rating (7) in the Biotechnology industry is somewhat better than the same rating for ATR (55) in the Containers Or Packaging industry. This means that A’s stock grew somewhat faster than ATR’s over the last 12 months.
A's P/E Growth Rating (39) in the Biotechnology industry is in the same range as ATR (39) in the Containers Or Packaging industry. This means that A’s stock grew similarly to ATR’s over the last 12 months.
| A | ATR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 64% | 1 day ago 52% |
| Stochastic ODDS (%) | 1 day ago 67% | 1 day ago 48% |
| Momentum ODDS (%) | 1 day ago 66% | 1 day ago 55% |
| MACD ODDS (%) | 1 day ago 64% | 1 day ago 62% |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 53% |
| TrendMonth ODDS (%) | 1 day ago 62% | 1 day ago 52% |
| Advances ODDS (%) | 7 days ago 62% | 1 day ago 54% |
| Declines ODDS (%) | 3 days ago 63% | 10 days ago 51% |
| BollingerBands ODDS (%) | 1 day ago 68% | 1 day ago 46% |
| Aroon ODDS (%) | 1 day ago 67% | 1 day ago 58% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
A’s FA Score shows that 2 FA rating(s) are green while ATR’s FA Score has 0 green FA rating(s).
- A’s FA Score: 2 green, 3 red.
- ATR’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
A’s TA Score shows that 3 TA indicator(s) are bullish while ATR’s TA Score has 4 bullish TA indicator(s).
- A’s TA Score: 3 bullish, 5 bearish.
- ATR’s TA Score: 4 bullish, 4 bearish.
Price Growth
A (@Medical Specialties) experienced а +0.82% price change this week, while ATR (@Pharmaceuticals: Other) price change was +5.50% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.98%. For the same industry, the average monthly price growth was -4.42%, and the average quarterly price growth was +44.30%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.41%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +7.68%.
Reported Earning Dates
A is expected to report earnings on Nov 23, 2026.
ATR is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Medical Specialties (+0.98% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Pharmaceuticals: Other (+1.41% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
ATR and
Correlation & Price change
A.I.dvisor indicates that over the last year, ATR has been loosely correlated with SYK. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATR jumps, then SYK could also see price increases.